Evaluation of aminoglutethimide in stage D prostate cancer: an assessment of efficacy and toxicity in patients with tumors refractory to hormonal therapy.
Block, M
Evaluation of aminoglutethimide in stage D prostate cancer: an assessment of efficacy and toxicity in patients with tumors refractory to hormonal therapy. [electronic resource] - Cancer treatment reports May 1984 - 719-22 p. digital
Publication Type: Journal Article
0361-5960
Aminoglutethimide--adverse effects
Antineoplastic Agents--therapeutic use
Aspartate Aminotransferases--blood
Drug Evaluation
Electrolytes--blood
Hormones--blood
Humans
Male
Middle Aged
Neoplasm Staging
Prostatic Neoplasms--drug therapy
Time Factors
Evaluation of aminoglutethimide in stage D prostate cancer: an assessment of efficacy and toxicity in patients with tumors refractory to hormonal therapy. [electronic resource] - Cancer treatment reports May 1984 - 719-22 p. digital
Publication Type: Journal Article
0361-5960
Aminoglutethimide--adverse effects
Antineoplastic Agents--therapeutic use
Aspartate Aminotransferases--blood
Drug Evaluation
Electrolytes--blood
Hormones--blood
Humans
Male
Middle Aged
Neoplasm Staging
Prostatic Neoplasms--drug therapy
Time Factors